The authors have previously reported that a sub-group of schizophrenic-likepatientsrespondfavorablyto lithium therapy: furthermore, psychoticpatientswho respondto lithium demonstrateappreciableimprove ment during the first seven days of treatment. The presentstudy investigated which symptomsof schizophreniaimprovedquicklyduring lithium treatment.
A sub-group of patients with a schizophrenic-like psychotic illness respond favourably to lithium therapy (Alexander et al, 1979; Hirschowitz et al, 1980 Hirschowitz et al, , 1982 Braden et al, 1982) . The reported advantages of lithium over neuroleptic treatment include a lower incidence of side-effects such as extrapyramidal symp toms, and of pathology attendent on chronic neurolep tic treatment, such as tardive dyskinesia. As less than 50 per cent of psychotic patients respond to lithium treatment alone (Zemlan et al, 1981) early prediction of lithium response is particularly important vis-d-vis early decisions on medication. Understandably, a major impediment to the greater use of lithium treatment for psychosis is the reluctance of physicians to take a patient into hospital for many weeks on medication that is ultimately ineffective.
Alexander et al (1979) reported that lithium responsive psychotic patients showed significant im provement during the first seven days of lithium treatment.The purpose of the presentpaper was twofold: to identify those psychotic symptoms which showed the greatest improvement during the initial week of lithium therapy; and to examine whether these identified symptoms would predict, on Day 7 of the lithium trial, lithium response/non-response at the end of the trial.
Methods
Sixty-one consenting in-patients presenting with schizophrenia or a schizoaffective disorder (RDC: Spitzer et al, 1978) entered the study; each was also diagnosed according to the criteria of DSM III (American PsychiatricAssociation, 1980) . After one week in hospital without drugs, patients started a two week trial of lithium carbonate at plasma levels adjusted to 1.0â€"1.4 meq/l. Patients' symptoms were assessed twice-weekly during the drug-free period and the lithium trial by trained personnel employing the serial New Haven Schizophrenic Index (NHSI: see Appendix for description). Patients showing an im provement greater than 40 per cent in their score on schizophrenic-like symptoms during the lithium trial were designated lithium responders. Statistical analysis of NHSI scores was by multivariate analysis of variance, followed by individual comparisons, where appropriate, of the differences between the Day 7 and the pre-lithium baseline NHSI scores. The distribution of these improvement scores was estimated by polyno mial regression analysis.
Information theory was employed to determine the best cut-off point for predicting final lithium response from Day 7 improvement scores. Information can be considered to represent a reduction in uncertainty. The increased information obtained from a seven-day lithium trial was calculated for each cut-off point and the probability of accurately predicting lithium re sponse by random guessing was subtracted. For example, the probability that a lithium responsive patient will be correctly predicted as such on Day 7 of the lithium trial is: 61) in the present group; P(LiNR) is the probability that a patient turns out to be a lithium non responder, 57 per cent (35/61) in the present group. We chose the cut-off point which reduced to a minimum the uncertainty of predicting response to lithium at the end of the lithium trial from response during the first seven days oflithium treatment.
Experimental Results

Total NHSI scores
Of the 61 in-patients presenting with RDC schizo phrenic symptoms, 26 demonstrated an improvement greater than 40 per cent by the end of the two-week lithium trial and were designated lithium responders (Table I) While significant improvement occurred in the core symptoms of psychosis during the first seven days of lithium treatment, no significant effects were found in the other NHSI Scales, although some significant improvements were observed after the second week of lithium treatment.
Predicting Lithium Response As the core symptoms of psychosisâ€"hallucinations, delusions and formal thought disorderâ€"demonstrated the greatest change during the first seven days of lithium treatment, scores on these symptoms were further analyzed to assess their ability to predict lithium response at the end of a lithium trial. As a group, patients judged to be lithium responders at Day 14 already demonstrated a mean 45 per cent improve ment in core symptoms by Day 7 (F = 26.56; d.f. =
1.59; P <0.0001), a significantly greater improvement
than the 0 per cent shown by the lithium non responsive group (Fig. 1) Daysoflithium treatment FIG1.â€"Averageimprovement in core psychotic symptoms (hallucinations, delusions and formal thought disorder) duringa lithiumtrial for lithium-responsive(n = 26)and non responsive(n = 35) patients. @@5P <0.0001.
The distribution of changes in scores on core symptoms was calculated for lithium-responders and non-responders (Fig. 2) . Equations describing the distributions were then determined by polynomial regression analysis. The distribution for responders was best described by the equation which accounted for 87 per cent of the variability in the changes in the scores.
As there was a significant difference between lithium responders and non-responders in the percent age improvement in core psychotic symptoms during the first seven days of lithium treatment, this figure was employed to check the predictability of response at the end of the lithium trial. Various criteria for prediction were examined between 10 per cent and 35 per cent improvement (Fig. 3 were also applied to the data from lithium non responders to check the predictability of non-respond ers at the end of the trial. 
Determination ofthe cut-off point
There are two major methods employed to select an appropriate cut-off for a clinical test: cost factoring (McNeil et al, 1975) , which determines the cut-off point by considering patient mortality, morbidity and health costs; and information theory (Lusted, 1971;  Metz et al, 1973), which we used in this study. The method of prior probabilities from Bayesian analysis showed that a cut-off point improvement greater than 20 per cent reduced to a minimum the uncertainty of predicting lithium response/non-response. (Bennington, 1981) .
Discussion
The present study demonstrates that a highly significant decrease in the core symptoms of psychosis occurs in schizophrenic patients during the first seven days of lithium treatment. This improvementâ€"in hallucinations, delusions and formal thought disor derâ€"suggests that lithium is a more rapidly acting antipsychotic agent than is normally assumed. How ever, Alexander et al (1979) Some authors consider it axiomatic that lithium is effective only in manic-depressive illness but not in â€˜¿ true' schizophrenia (Procci, 1976; Pope & Lipinski, 1978) : the affective dysregulation is thought to drive the psychotic symptoms. Lithium is thus supposed to act first on the affective symptoms; then, as a secondary effect, on the psychosis. However, in the present study of patients presenting with classical schizophrenic symptoms, lithium significantly im proved core psychotic symptoms-hallucinations, de lusions and formal thought disorderâ€"during the first seven days of treatment. This rapid effect on psychosis appears to occur prior to any influence on the affective component of the patients' illness. To resolve this issue specifically independent measures of affective and psychotic symptoms must be made, and the time course of remission of individual symptoms deter mined. This question is currently under active investigation.
In the present study, the mean score on the DelusionScale incidenceof auditory hallucinations.The maximumpossible was between 3 and 4, out of a possible 5. The maximum score on the Formal Thought Disorder Scale is 20 points: possible score on the Hallucinations Scale is 15, but in our mean score of between 7 and 8 seen in the present patient study sample hallucinations were almost exclusively limited sample indicates a uniformly substantial incidence of thought to auditory hallucinations, giving a maximum score of 5: our disorder.
mean score of between 3 and 4 on this scale reflects a high (â€˜Received J7November 1982) 
